The purpose of this study is to determine if treatment with albendazole improves the clinical
outcome of neurocysticercosis infection and/or leads to the disappearance of cysts sooner
when compared with symptomatic treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Columbia University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)